When it comes to the spinal cord stimulation market, Abbott Laboratories Inc., Medtronic PLC and Boston Scientific Corp. are on top of the world, but one start-up from Down Under hopes to "evoke" an entirely new response.
In contrast to existing spinal cord stimulation (SCS) systems that treat chronic pain by generating the same stimulation output through fixed (open-looped) technology, Evoke from Saluda Medical Pty. Ltd.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?